Xiandao Q. Pan
Beijing Key Laboratory Of Active Substances Discovery And Druggability Evaluation, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery of 1H-Indole-3-Propionamide Derivatives as Potent, Selective and Orally Available NaV1.7 Inhibitors for Pain Treatment.
Journal: Journal of medicinal chemistry
Published: July 27, 2026
PaAP-Activatable NIR Probe for Diagnosing, Imaging, and Discovering Small-Molecule Therapeutics against Implant-Associated Biofilm Infections.
Journal: Journal of medicinal chemistry
Published: March 26, 2025
Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy.
Journal: Acta pharmaceutica Sinica. B
Published: March 04, 2025
RSGPT: a generative transformer model for retrosynthesis planning pre-trained on ten billion datapoints.
Journal: Nature communications
Published: November 11, 2024
Application of 3D-printed navigation plate in pulsed radiofrequency therapy of dorsal root ganglion in thoracic postherpetic neuralgia
Journal: Zhonghua yi xue za zhi
Published: November 22, 2021
Research Progress on the Natural Product Aloperine and Its Derivatives.
Journal: Mini reviews in medicinal chemistry
Published: December 06, 2020
Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
Journal: Frontiers in cellular and infection microbiology
Published: May 10, 2019
Synthetic Optimization of Ellipticine and Antitumor Activity of Novel Hexacyclic Derivatives of Ellipticine.
Journal: Current pharmaceutical design
Published: December 12, 2018
Synthesis of High Purified Tulobuterol and Its Study of the Organic Impurities.
Journal: Journal of chromatographic science
Published: October 11, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026